Clinical Trials
25 trialsNCT06200168 2025-04-02
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
Affiliated Hospital of Qinghai University
Phase 3 Recruiting
NCT02116530 2025-01-28
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT06588413 2024-11-22
FONDO-LOW
Augusta University
Phase 3 Recruiting
NCT02939287 2024-10-22
Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
Rush University Medical Center
Phase 3 Completed
NCT06314906 2024-03-21
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Lanzhou University Second Hospital
Phase 3 Recruiting
NCT06017284 2023-11-24
PTCA199-5
Fudan University
Phase 3 Recruiting
NCT05244577 2023-02-06
Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT01536392 2021-06-11
Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01661335 2021-03-23
Efficacy of Aprepitant (Emend®) in Children
University of Oklahoma
Phase 3 Completed
NCT00553059 2020-10-09
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
M.D. Anderson Cancer Center
Phase 3 Completed
NCT04201769 2020-04-03
LUNG-NEPA
Consorzio Oncotech
Phase 3 Unknown
NCT00206440 2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3 Terminated
NCT00046865 2018-11-14
Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
M.D. Anderson Cancer Center
Phase 3 Completed
NCT02028832 2017-05-08
PIM
University of Alberta
Phase 3 Completed
NCT00006348 2016-07-06
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00880191 2016-07-06
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00475085 2015-11-10
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
University of Rochester
Phase 3 Completed
NCT00020657 2015-10-15
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
University of Rochester
Phase 3 Completed
NCT01132547 2015-07-02
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
University of South Florida
Phase 3 Terminated
NCT01074697 2015-04-24
GAND-emesis
Odense University Hospital
Phase 3 Completed
NCT00003213 2012-07-11
Drugs to Reduce the Side Effects of Chemotherapy
Swiss Cancer Institute
Phase 3 Completed
NCT00152867 2012-06-28
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy
University Health Network, Toronto
Phase 3 Completed
NCT00124930 2012-01-19
Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer
AHS Cancer Control Alberta
Phase 3 Terminated
NCT00409071 2010-02-05
Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.
Centre Leon Berard
Phase 3 Completed
NCT00268125 2009-03-18
Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.
Institut Claudius Regaud
Phase 3 Completed